News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
697,308 Results
Type
Article (39618)
Company Profile (247)
Press Release (657443)
Multimedia
Podcasts (47)
Webinars (12)
Section
Business (204126)
Career Advice (2007)
Deals (35413)
Drug Delivery (95)
Drug Development (81031)
Employer Resources (172)
FDA (16168)
Job Trends (14850)
News (345111)
Policy (32522)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (5)
2024 Genetown Standard (8)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (4)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Standard (2)
Academia (2553)
Accelerated approval (5)
Adcomms (20)
Allergies (82)
Alliances (49401)
ALS (86)
Alzheimer's disease (1369)
Antibody-drug conjugate (ADC) (112)
Approvals (16170)
Artificial intelligence (241)
Autoimmune disease (20)
Automation (15)
Bankruptcy (360)
Best Places to Work (11636)
BIOSECURE Act (18)
Biosimilars (104)
Biotechnology (175)
Bladder cancer (60)
Brain cancer (26)
Breast cancer (262)
Cancer (2083)
Cardiovascular disease (167)
Career advice (1674)
Career pathing (29)
CAR-T (143)
Cell therapy (403)
Cervical cancer (19)
Clinical research (65834)
Collaboration (794)
Compensation (508)
Complete response letters (19)
COVID-19 (2582)
CRISPR (37)
C-suite (223)
Cystic fibrosis (100)
Data (2051)
Decentralized trials (2)
Denatured (17)
Depression (39)
Diabetes (256)
Diagnostics (6350)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (118)
Drug pricing (96)
Drug shortages (25)
Duchenne muscular dystrophy (91)
Earnings (86338)
Editorial (35)
Employer branding (21)
Employer resources (146)
Events (111889)
Executive appointments (693)
FDA (17352)
Featured Employer (47)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (718)
Gene editing (100)
Generative AI (19)
Gene therapy (285)
GLP-1 (697)
Government (4405)
Grass and pollen (4)
Guidances (51)
Healthcare (18811)
Huntington's disease (23)
IgA nephropathy (24)
Immunology and inflammation (109)
Indications (26)
Infectious disease (2722)
Inflammatory bowel disease (133)
Inflation Reduction Act (8)
Influenza (50)
Intellectual property (91)
Interviews (311)
IPO (16494)
IRA (40)
Job creations (3628)
Job search strategy (1422)
Kidney cancer (9)
Labor market (36)
Layoffs (460)
Leadership (16)
Legal (7905)
Liver cancer (72)
Lung cancer (302)
Lymphoma (139)
Machine learning (5)
Management (58)
Manufacturing (282)
MASH (62)
Medical device (13345)
Medtech (13350)
Mergers & acquisitions (19434)
Metabolic disorders (655)
Multiple sclerosis (75)
NASH (16)
Neurodegenerative disease (83)
Neuropsychiatric disorders (24)
Neuroscience (1874)
NextGen: Class of 2025 (6512)
Non-profit (4476)
Northern California (2533)
Now hiring (38)
Obesity (353)
Opinion (203)
Ovarian cancer (73)
Pain (80)
Pancreatic cancer (80)
Parkinson's disease (146)
Partnered (21)
Patents (222)
Patient recruitment (99)
Peanut (46)
People (57206)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20504)
Phase II (28988)
Phase III (21606)
Pipeline (1115)
Policy (130)
Postmarket research (2563)
Preclinical (8675)
Press Release (64)
Prostate cancer (98)
Psychedelics (30)
Radiopharmaceuticals (244)
Rare diseases (371)
Real estate (5906)
Recruiting (65)
Regulatory (22200)
Reports (46)
Research institute (2320)
Resumes & cover letters (349)
Rett syndrome (4)
RNA editing (4)
RSV (42)
Schizophrenia (65)
Series A (124)
Series B (81)
Service/supplier (11)
Sickle cell disease (52)
Southern California (2179)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (28)
Startups (3572)
State (2)
Stomach cancer (13)
Supply chain (65)
Tariffs (24)
The Weekly (28)
United States (21996)
Vaccines (668)
Venture capitalists (38)
Weight loss (229)
Women's health (34)
Worklife (15)
Date
Last 7 days (468)
Last 30 days (2154)
Last 365 days (32795)
2025 (9203)
2024 (35218)
2023 (40079)
2022 (51173)
2021 (55710)
2020 (54083)
2019 (46538)
2018 (35018)
2017 (32109)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (718)
Alabama (52)
Alaska (7)
Arizona (229)
Arkansas (13)
Asia (37752)
Australia (6176)
California (5776)
Canada (1939)
China (489)
Colorado (253)
Connecticut (262)
Delaware (134)
Europe (81017)
Florida (860)
Georgia (202)
Idaho (57)
Illinois (513)
India (25)
Indiana (300)
Iowa (9)
Japan (149)
Kansas (102)
Kentucky (23)
Louisiana (9)
Maine (62)
Maryland (856)
Massachusetts (4330)
Michigan (215)
Minnesota (378)
Mississippi (2)
Missouri (78)
Montana (27)
Nebraska (25)
Nevada (60)
New Hampshire (62)
New Jersey (1659)
New Mexico (28)
New York (1650)
North Carolina (935)
North Dakota (7)
Northern California (2533)
Ohio (194)
Oklahoma (14)
Oregon (33)
Pennsylvania (1305)
Puerto Rico (11)
Rhode Island (30)
South America (1096)
South Carolina (20)
South Dakota (1)
Southern California (2179)
Tennessee (99)
Texas (860)
Utah (171)
Virginia (135)
Washington D.C. (59)
Washington State (530)
West Virginia (3)
Wisconsin (51)
697,308 Results for "amprion inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Amprion Announces Landmark Study in The Lancet Neurology
November 21, 2024
·
3 min read
Press Releases
Amprion Announces Initial Close of a $15M Financing to Commercialize Groundbreaking Neurologic Diagnostics
October 9, 2024
·
3 min read
Biotech Beach
Amprion’s αSyn Seed Amplification Assay (αS-SAA) Highlighted in 10 Presentations at AD/PD™ 2024 International Conference
Amprion is pleased to announce its presence at the AD/PD™ 2024 International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders in Lisbon, Portugal on March 5-9.
March 4, 2024
·
5 min read
Biotech Beach
Amprion Announces Collaboration with NIH Researchers on Dementia Hallmark Study
Amprion has been contracted by the National Institutes of Health Intramural Research Program’s Center for Alzheimer’s and Related Dementias to study the levels of misfolded alpha-synuclein proteins in people with Alzheimer’s disease.
August 23, 2023
·
4 min read
Biotech Beach
Amprion Announces Granting of European Patents for Seed Amplification Assay Platform
Amprion, a global leader in neurodegenerative disease diagnostics, continues to fortify its Intellectual Property surrounding the company’s proprietary methodology for highly sensitive detection of misfolded proteins and amyloid-like aggregates.
August 15, 2023
·
3 min read
Biotech Beach
Amprion’s αSynuclein Seed Amplification Assay to be Showcased at Alzheimer’s Association International Conference® 2023 (AAIC®)
Amprion, a global leader in the advancement of neurodegenerative disorder diagnosis, will be in attendance at the Alzheimer’s Association International Conference® 2023 in Amsterdam on July 16-20.
July 15, 2023
·
4 min read
Biotech Beach
Amprion showcases SYNTap® Biomarker Test at AD/PD™ 2023 International Conference
Amprion is pleased to announce its attendance at the AD/PD™ 2023 International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders in Gothenburg, Sweden on March 28-April 1.
March 27, 2023
·
4 min read
Biotech Beach
Amprion Announces Presentation of Findings Related to Usage of the αSynuclein Seed Amplification Assay in Recent Parkinson’s Study at 2023 AAN Annual Meeting
Amprion is pleased to announce that it will attend the American Academy of Neurology (AAN) Annual Meeting in Boston April 22-27 to share insights about its SYNTap Biomarker Test, a first-in-class qualitative Laboratory Developed Test (LDT) and the only seed amplification assay available to aid physicians in diagnosing synucleinopathies.
April 21, 2023
·
5 min read
Press Releases
Nika Pharmaceuticals, Inc. (NIKA) Latest Developments
April 14, 2025
·
2 min read
Press Releases
FDA Classifies Q’Apel Medical Inc.'s Worldwide Medical Device Recall and Discontinuation of its 072 Aspiration System (Hippo) as Class I
April 18, 2025
·
4 min read
1 of 69,731
Next
